<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2021</study_start_year><condition>Colorectal cancer metastatic</condition><condition>Metastases from Colorectal Cancer</condition><disease>Colorectal Cancer Metastatic</disease><disease>Metastases From Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2540825</full_dataset_link><location>Norway</location><study_start_month>3</study_start_month><keyword>Oksaliplatin</keyword><repository>ECRIN MDR</repository><study_status>Ongoing</study_status></additional><is_claimable>false</is_claimable><name>NORMOTHERMIC INTRAPERITONEAL CHEMOTHERAPY IN PERITONEAL METASTASES FROM COLORECTAL CANCER – FEASIBILITY STUDY (NIPEC-OXA)</name><description>Primary objectives: Analysis of chemotherapy toxicity given through i.p. during NIPEC-OXA throughout the entire treatment period, including a 3-month follow-up.
Primary endpoints: Adverse Event meassured by CTCAE 5.0</description><dates><creation>2021-03-15</creation></dates><accession>2540825</accession><cross_references><EU Clinical Trials Register>2020-004944-27</EU Clinical Trials Register></cross_references></HashMap>